[ET Net News Agency, 4 June 2019] Luye Pharma Group Ltd. (02186) announced that the
group's "Acarbose Capsules" (brand name "Bei Xi") has been granted approval by the
National Medical Products Administration for passing the Consistency of Quality and
Efficacy Evaluation of Generic Drugs.
Bei Xi is indicated for reducing blood glucose in patients with type 2 diabetes
mellitus, and reducing postprandial blood glucose in patients with impaired glucose
tolerance. (RC)